ВЛИЯНИЕ БРОМОКРИПТИНА НА КЛИНИКО-ГЕМОДИНАМИЧЕСКИЕ ПАРАМЕТРЫ БОЛЬНЫХ ПЕРИПАРТАЛЬНОЙ КАРДИОМИОПАТИЕЙ

Purpose. Evaluation of the effect of bromocriptine on the clinical and hemodynamic parameters in patients with PCMP. Materials and methods. We examined 98 patients with PCMP who were prescribed the drug bromocriptine 2.5 mg 2 times a day for 30 days. CE, 6MWT, ECG, EchoCG were performed. The results of the study. According to EchoCG during therapy with bromocriptine, LVEF increased by 12 %, LVESD decreased by 9 %. The initial heart rate (HR) decreased by 9 % (from 88,8 ± 14.4 to 78,2 ± 12,2 beats per min), the level of initially low arterial pressure (BP) increased to 94,6 ± 6,4 up to 98,6 ± 4,4 mm Hg Findings. The results of our study demonstrated positive dynamics both in clinical status and in parameters of central and intracardiac hemodynamics.